Karyopharm Therapeutics Inc. (KPTI) Free Cash Flow

Karyopharm Therapeutics Inc. (KPTI) free cash flow history and trends. Track FCF in Excel with MarketXLS.

Free Cash Flow Data

PeriodFree Cash Flow (USD)
2016-12-31-$84.46M
2017-12-31-$73.78M
2018-12-31-$161.51M
2019-12-31-$191.03M
2020-12-31-$160.38M
2021-12-31-$112.83M
2022-12-31-$149.55M
2023-12-31-$92.72M
2024-12-31-$127.63M
2025-12-31-$75.37M

How KPTI compares with sector peers

SymbolCompanyFree cash flow (latest fiscal year)
VTGNVistagen Therapeutics Inc.-$66.44M
ALTAltimmune Inc.-$67.55M
LXRXLexicon Pharmaceuticals Inc.-$67.85M
QTRXQuanterix Corporation-$79.85M
ABEOAbeona Therapeutics Inc.-$84.30M

These are five companies in the same sector as KPTI with a comparable annual free cash flow. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.

Get Karyopharm Therapeutics Inc. Data in Excel

Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.

Try: =hf_Free_Cash_Flow("KPTI", 2024)

BUY NOW